PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.\', \'Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.\', \'Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.\', \'Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia.\', \'Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.\', \'Division of Personalised Oncology, Walter and Eliza Hall Research Institute, Melbourne, Australia.\', \'Department Medical Oncology, Western Health, Melbourne, Australia.\', \'Department of Surgery, University of Melbourne, Melbourne, Australia.\', \'Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.\', \'Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.\', \'Health Technology and Services Research, Technical Medical Centre, Faculty of Behavioural, Management and Social Sciences, University of Twente, Enschede, the Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ajco.13505
?:hasPublicationType
?:journal
  • Asia-Pacific journal of clinical oncology
is ?:pmid of
?:pmid
?:pmid
  • 33567163
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.58
?:rankingScore_hIndex
  • 20
is ?:relation_isRelatedTo_publication of
?:title
  • An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all